Literature DB >> 12165143

Borrelia burgdorferi-specific monoclonal antibodies derived from mice primed with Lyme disease spirochete-infected Ixodes scapularis ticks.

M Lamine Mbow1, Robert D Gilmore, Brian Stevenson, William T Golde, Joseph Piesman, Barbara J B Johnson.   

Abstract

We have generated a panel of IgG monoclonal antibodies (MAbs) directed against Borrelia burgdorferi strain B31 antigens, using a method whereby mice were primed with organisms naturally inoculated by Ixodes scapularis nymphal ticks. Western blot analysis showed that these MAbs recognized several B. burgdorferi B31 antigens, including the complement inhibitor factor H-binding proteins ErpA/I/N and ErpC. Two other MAbs were specific for the RevA protein, and have enabled characterization of that previously unknown protein. The data presented here suggest that the production of MAbs from animals infected by tick-bite is a potentially useful tool for the identification of novel proteins synthesized by B. burgdorferi during mammalian infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12165143     DOI: 10.1089/153685902760173890

Source DB:  PubMed          Journal:  Hybrid Hybridomics        ISSN: 1536-8599


  7 in total

1.  Borrelia burgdorferi RevA Significantly Affects Pathogenicity and Host Response in the Mouse Model of Lyme Disease.

Authors:  Rebecca Byram; Robert A Gaultney; Angela M Floden; Christopher Hellekson; Brandee L Stone; Amy Bowman; Brian Stevenson; Barbara J B Johnson; Catherine A Brissette
Journal:  Infect Immun       Date:  2015-07-06       Impact factor: 3.441

2.  Complement factor H-related proteins CFHR2 and CFHR5 represent novel ligands for the infection-associated CRASP proteins of Borrelia burgdorferi.

Authors:  Corinna Siegel; Teresia Hallström; Christine Skerka; Hannes Eberhardt; Barbara Uzonyi; Tobias Beckhaus; Michael Karas; Reinhard Wallich; Brian Stevenson; Peter F Zipfel; Peter Kraiczy
Journal:  PLoS One       Date:  2010-10-20       Impact factor: 3.240

3.  Evaluation of RevA, a fibronectin-binding protein of Borrelia burgdorferi, as a potential vaccine candidate for lyme disease.

Authors:  Angela M Floden; Tammy Gonzalez; Robert A Gaultney; Catherine A Brissette
Journal:  Clin Vaccine Immunol       Date:  2013-04-17

4.  Analysis of Borrelia burgdorferi Surface Proteins as Determinants in Establishing Host Cell Interactions.

Authors:  Virginia L Schmit; Toni G Patton; Robert D Gilmore
Journal:  Front Microbiol       Date:  2011-07-01       Impact factor: 5.640

5.  Borrelia burgdorferi enolase is a surface-exposed plasminogen binding protein.

Authors:  Angela M Floden; John A Watt; Catherine A Brissette
Journal:  PLoS One       Date:  2011-11-08       Impact factor: 3.240

6.  Bpur, the Lyme disease spirochete's PUR domain protein: identification as a transcriptional modulator and characterization of nucleic acid interactions.

Authors:  Brandon L Jutras; Alicia M Chenail; Dustin W Carroll; M Clarke Miller; Haining Zhu; Amy Bowman; Brian Stevenson
Journal:  J Biol Chem       Date:  2013-07-11       Impact factor: 5.157

Review 7.  That's my story, and I'm sticking to it--an update on B. burgdorferi adhesins.

Authors:  Catherine A Brissette; Robert A Gaultney
Journal:  Front Cell Infect Microbiol       Date:  2014-04-03       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.